Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)
Stephen H. Petersdorf, Cathryn Rankin, David R. Head, Howard R. Terebelo, Cheryl L. Willman, Stanley P. Balcerzak, Anand B. Karnad, Shaker R. Dakhil, Frederick R. Appelbaum
Dive into the research topics of 'Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: A southwest oncology group study (SWOG-9500)'. Together they form a unique fingerprint.